MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo. uri icon

authors

  • Fiedler, Lorna R
  • Jarvis, Ashley
  • Newton, Gary
  • Paiva, Marta Abreu
  • Harada, Mutsuo
  • Stuckey, Daniel J
  • Song, Weihua
  • Habib, Josef
  • Narasimhan, Priyanka
  • Aqil, Rehan
  • Sanmugalingam, Devika
  • Chapman, Kathryn
  • Yan, Robert
  • Pavanello, Lorenzo
  • Sano, Motoaki
  • Wang, Sam C
  • Sampson, Robert D
  • Kanayaganam, Sunthar
  • George E Taffet, MD
  • Michael, Lloyd H
  • Entman, Mark L
  • Tan, Tse-Hua
  • Xie, Min
  • Harding, Sian E
  • Low, Caroline M R
  • Tralau-Stewart, Catherine
  • Perrior, Trevor
  • Schneider, Michael D
  • Maifoshie, Evie
  • Jenkins, Micaela
  • Golforoush, Pelin Arabacilar
  • Bellahcene, Mohamed
  • Noseda, Michela
  • Faust, Dörte

publication date

  • January 1, 2019